Fact CheckerSign in

NCT06730997Not yet recruiting

Clinicopathological Features of Renal Cell Carcinoma in Young Patients

Clinicopathological Features of Renal Cell Carcinoma in Young Patients and it's Influence on the Survival Outcome

Source: ClinicalTrials.gov · Last updated 12 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Analysis of Clinicopathologic Characters of Renal Cell Carcinoma in Young Patients and their influence on the survival outcomes

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
100 (estimated)
First submitted
9 Dec 2024
Start date
1 Jan 2025
Primary completion date
1 Feb 2027
Lead sponsor
Assiut University
NCT number
NCT06730997

What you commit to

  • Study type: Observational
  • Planned participants: 100
  • From 1 Jan 2025 to the primary completion date, 1 Feb 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Second malignancy.

Who the study is looking for

  • Age \< 40 years
    • Patients proven to have RCC
    • Patients eligible to receive treatment

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.